PAKRX vs. PRCOX
Compare and contrast key facts about T. Rowe Price Target 2030 Fund (PAKRX) and T. Rowe Price U.S. Equity Research Fund (PRCOX).
PAKRX is managed by T. Rowe Price. It was launched on Aug 19, 2013. PRCOX is managed by T. Rowe Price. It was launched on Nov 30, 1994.
Performance
PAKRX vs. PRCOX - Performance Comparison
Loading graphics...
PAKRX vs. PRCOX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PAKRX T. Rowe Price Target 2030 Fund | -0.47% | 12.52% | 9.22% | 13.85% | -15.44% | 11.09% | 13.88% | 19.12% | -5.51% | 14.63% |
PRCOX T. Rowe Price U.S. Equity Research Fund | -4.40% | 16.97% | 26.41% | 29.82% | -18.80% | 28.06% | 19.82% | 33.04% | -4.73% | 23.80% |
Returns By Period
In the year-to-date period, PAKRX achieves a -0.47% return, which is significantly higher than PRCOX's -4.40% return. Over the past 10 years, PAKRX has underperformed PRCOX with an annualized return of 7.19%, while PRCOX has yielded a comparatively higher 14.64% annualized return.
PAKRX
- 1D
- 1.51%
- 1M
- -3.84%
- YTD
- -0.47%
- 6M
- 1.11%
- 1Y
- 10.50%
- 3Y*
- 9.97%
- 5Y*
- 4.63%
- 10Y*
- 7.19%
PRCOX
- 1D
- 3.03%
- 1M
- -5.43%
- YTD
- -4.40%
- 6M
- -1.63%
- 1Y
- 17.03%
- 3Y*
- 19.27%
- 5Y*
- 12.31%
- 10Y*
- 14.64%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PAKRX vs. PRCOX - Expense Ratio Comparison
PAKRX has a 0.81% expense ratio, which is higher than PRCOX's 0.42% expense ratio.
Return for Risk
PAKRX vs. PRCOX — Risk / Return Rank
PAKRX
PRCOX
PAKRX vs. PRCOX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Target 2030 Fund (PAKRX) and T. Rowe Price U.S. Equity Research Fund (PRCOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PAKRX | PRCOX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.23 | 0.97 | +0.27 |
Sortino ratioReturn per unit of downside risk | 1.78 | 1.49 | +0.29 |
Omega ratioGain probability vs. loss probability | 1.27 | 1.22 | +0.04 |
Calmar ratioReturn relative to maximum drawdown | 1.35 | 1.29 | +0.06 |
Martin ratioReturn relative to average drawdown | 6.13 | 6.07 | +0.06 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PAKRX | PRCOX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.23 | 0.97 | +0.27 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.51 | 0.72 | -0.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.73 | 0.80 | -0.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.70 | 0.55 | +0.15 |
Correlation
The correlation between PAKRX and PRCOX is 0.92, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
PAKRX vs. PRCOX - Dividend Comparison
PAKRX's dividend yield for the trailing twelve months is around 7.19%, more than PRCOX's 1.80% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PAKRX T. Rowe Price Target 2030 Fund | 7.19% | 7.16% | 4.31% | 3.54% | 6.16% | 3.54% | 2.99% | 3.62% | 5.26% | 1.90% | 1.79% | 1.76% |
PRCOX T. Rowe Price U.S. Equity Research Fund | 1.80% | 1.72% | 0.64% | 1.17% | 1.28% | 3.71% | 1.04% | 1.39% | 5.60% | 7.02% | 7.28% | 8.76% |
Drawdowns
PAKRX vs. PRCOX - Drawdown Comparison
The maximum PAKRX drawdown since its inception was -24.66%, smaller than the maximum PRCOX drawdown of -53.96%. Use the drawdown chart below to compare losses from any high point for PAKRX and PRCOX.
Loading graphics...
Drawdown Indicators
| PAKRX | PRCOX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -24.66% | -53.96% | +29.30% |
Max Drawdown (1Y)Largest decline over 1 year | -6.75% | -12.19% | +5.44% |
Max Drawdown (5Y)Largest decline over 5 years | -21.65% | -24.94% | +3.29% |
Max Drawdown (10Y)Largest decline over 10 years | -24.66% | -34.42% | +9.76% |
Current DrawdownCurrent decline from peak | -4.22% | -6.57% | +2.35% |
Average DrawdownAverage peak-to-trough decline | -3.74% | -9.22% | +5.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.61% | 2.59% | -0.98% |
Volatility
PAKRX vs. PRCOX - Volatility Comparison
The current volatility for T. Rowe Price Target 2030 Fund (PAKRX) is 3.39%, while T. Rowe Price U.S. Equity Research Fund (PRCOX) has a volatility of 5.63%. This indicates that PAKRX experiences smaller price fluctuations and is considered to be less risky than PRCOX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PAKRX | PRCOX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.39% | 5.63% | -2.24% |
Volatility (6M)Calculated over the trailing 6-month period | 5.34% | 9.35% | -4.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 9.00% | 18.35% | -9.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 9.20% | 17.33% | -8.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 9.94% | 18.33% | -8.39% |